12:00 AM
 | 
Sep 08, 2008
 |  BC Week In Review  |  Clinical News  |  Clinical Status

TM30339: Phase I/II started

7TM Pharma began a double-blind, placebo-controlled, U.S. Phase I/Ila trial to evaluate TM30339 in patients with a BMI of...

Read the full 75 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >